Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

US CDC avoids mandating antigen test to end five-day COVID-19 isolation

Published 01/04/2022, 06:04 PM
Updated 01/04/2022, 06:06 PM
© Reuters. People wait for COVID-19 testing at an outdoor testing site amid the spread of coronavirus disease (COVID-19) in Newark, New Jersey, U.S., January 4, 2022. REUTERS/Mike Segar

© Reuters. People wait for COVID-19 testing at an outdoor testing site amid the spread of coronavirus disease (COVID-19) in Newark, New Jersey, U.S., January 4, 2022. REUTERS/Mike Segar

(Reuters) - The U.S. Centers for Disease Control and Prevention said on Tuesday people seeking to end their COVID-19 isolation at five days can opt for a rapid antigen test, but stopped short of mandating the test despite pressure by health experts.

"If an individual has access to a test and wants to test, the best approach is to use an antigen test towards the end of the 5-day isolation period," the agency said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.